Cibc Private Wealth Group, LLC En V Veno Medical Corp Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in En V Veno Medical Corp stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 860 shares of NVNO stock, worth $559. This represents 0.0% of its overall portfolio holdings.
Number of Shares
860
Previous 860
-0.0%
Holding current value
$559
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NVNO
# of Institutions
41Shares Held
5.22MCall Options Held
29KPut Options Held
0-
Perceptive Advisors LLC New York, NY1.28MShares$835,2270.23% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY859KShares$558,5190.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA698KShares$453,9200.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT595KShares$386,5290.1% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$260,7803.48% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $6.16M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...